Cefuroxime
Active substance: cefuroxime
INJECTION, POWDER, FOR SOLUTION · CEFUROXIME SODIUM 750 mg/8mL
United StatesActive
Marketing holder: Hikma Pharmaceuticals USA Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- CEFUROXIME SODIUM · 750 mg/8mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 52 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4da9-7ad6-9b82-761ee0aaf1ce,01a1208c-5998-7831-bad4-ebfe37f25061,01a1208c-599c-71c9-a06d-25a845371045,01a1208d-17f1-7639-b839-163524fdf604,01a1208e-94a9-712b-812f-a440740f310c;count=10 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0143-9976
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0143-9976 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0143-9976 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0143-9976 · Verified 2026-10-09 · open in source